ACGKX | VIVAX | ACGKX / VIVAX | |
Total Expense Ratio | 1.52 | 0.17 | 894% |
Annual Report Gross Expense Ratio | 1.52 | 0.17 | 894% |
Fund Existence | 32 years | 33 years | - |
Gain YTD | 8.107 | 6.724 | 121% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.19B | 195B | 2% |
Annual Yield % from dividends | 0.42 | 2.06 | 20% |
Returns for 1 year | 4.27 | 9.76 | 44% |
Returns for 3 years | 7.15 | 34.31 | 21% |
Returns for 5 years | 22.97 | 74.87 | 31% |
Returns for 10 years | -10.39 | 116.32 | -9% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ERHSX | 14.30 | 0.07 | +0.49% |
Eaton Vance Worldwide Health Sci R | |||
CSRYX | 39.45 | 0.16 | +0.41% |
Columbia Select Large Cap Value Inst3 | |||
TRMIX | 32.36 | 0.12 | +0.37% |
T. Rowe Price Mid-Cap Value I | |||
QABGX | 23.14 | 0.08 | +0.35% |
Federated Hermes MDT Balanced A | |||
LPEIX | 7.25 | 0.01 | +0.14% |
ALPS Global Opportunity I |